Personalis Total Long-Term Assets 2018-2024 | PSNL
Personalis total long-term assets from 2018 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Personalis Annual Total Long-Term Assets
(Millions of US $) |
| 2023 |
$78 |
| 2022 |
$93 |
| 2021 |
$78 |
| 2020 |
$24 |
| 2019 |
$18 |
| 2018 |
$12 |
| 2017 |
$ |
Personalis Quarterly Total Long-Term Assets
(Millions of US $) |
| 2024-06-30 |
$72 |
| 2024-03-31 |
$75 |
| 2023-12-31 |
$78 |
| 2023-09-30 |
$78 |
| 2023-06-30 |
$88 |
| 2023-03-31 |
$89 |
| 2022-12-31 |
$93 |
| 2022-09-30 |
$96 |
| 2022-06-30 |
$98 |
| 2022-03-31 |
$87 |
| 2021-12-31 |
$78 |
| 2021-09-30 |
$78 |
| 2021-06-30 |
$29 |
| 2021-03-31 |
$23 |
| 2020-12-31 |
$24 |
| 2020-09-30 |
$25 |
| 2020-06-30 |
$25 |
| 2020-03-31 |
$16 |
| 2019-12-31 |
$18 |
| 2019-09-30 |
$19 |
| 2019-06-30 |
$16 |
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.315B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
